Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | PRKCA | P17252 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3997236 | 0.91 | TSHR (0.39) | POLBGAANPSR1PRKCATSHR | |
| SCHEMBL10990413 | 0.91 | TSHR (0.39) | POLBGAANPSR1PRKCATSHR | |
| SCHEMBL720297 | 0.86 | POLB (0.43) | POLBGAANPSR1PRKCAALDH1A1 | |
| SCHEMBL27819169 | 0.85 | POLB (0.46) | POLBGAANPSR1PRKCATSHR | |
| SCHEMBL7989588 | 0.85 | POLB (0.46) | POLBGAANPSR1PRKCATSHR | |
| SCHEMBL29049106 | 0.83 | POLB (0.44) | POLBGAANPSR1PRKCATSHR | |
| SCHEMBL4953953 | 0.83 | POLB (0.35) | POLBGAANPSR1TSHRALDH1A1 | |
| SCHEMBL4258156 | 0.80 | POLB (0.48) | POLBGAANPSR1PRKCATSHR | |
| SCHEMBL126843 | 0.79 | ALDH1A1 (0.56) | POLBGAANPSR1TSHRALDH1A1 | |
| SCHEMBL2531853 | 0.79 | CYP4F2 (0.47) | POLBGAANPSR1PRKCAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11591426-B2 | Copolymer, wetting agent, medical device, and method for producing same | TORAY INDUSTRIES, INC. (JP) | 2023-02-28 | — | — | US | disclosed |
| EP-3438144-B1 | COPOLYMER, WETTING AGENT, MEDICAL DEVICE, AND METHOD FOR PRODUCING SAME | TORAY INDUSTRIES (JP) | 2021-06-30 | — | — | EP | disclosed |
| US-20210015960-A1 | COPOLYMER, WETTING AGENT, MEDICAL DEVICE, AND METHOD FOR PRODUCING SAME | TORAY INDUSTRIES, INC. (JP) | 2021-01-21 | — | — | US | disclosed |
| US-20190099511-A1 | COPOLYMER, WETTING AGENT, MEDICAL DEVICE, AND METHOD FOR PRODUCING SAME | TORAY INDUSTRIES, INC. (JP) | 2019-04-04 | — | — | US | disclosed |
| EP-3438144-A1 | COPOLYMER, WETTING AGENT, MEDICAL DEVICE, AND METHOD FOR PRODUCING SAME | Toray Industries, Inc. (JP) | 2019-02-06 | — | — | EP | disclosed |
| EP-2217564-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XenoPort, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| US-20090076147-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. | 2009-03-19 | — | — | US | disclosed |
| WO-2009033054-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| EP-0940383-B1 | Method for the selective alkylation of aldehydes with organozinc compounds | CHEMETALL GMBH (DE) | 2003-06-18 | — | — | EP | disclosed |
| EP-0664782-B2 | ENANTIOMERIC RESOLUTION | ALBEMARLE CORP (US) | 2001-02-14 | — | — | EP | disclosed |
| WO-1994008934-A1 | ENANTIOMERIC RESOLUTION | ALBEMARLE CORPORATION (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1994008936-A1 | ENANTIOMERIC RESOLUTION | ALBEMARLE CORPORATION (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1994008935-A1 | ENANTIOMERIC RESOLUTION | ALBEMARLE CORPORATION (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1994008937-A1 | ENANTIOMERIC RESOLUTION | ALBEMARLE CORPORATION (US) | 1994-04-28 | — | — | WO | disclosed |
| US-5278337-A | Enantiomeric resolution of aryl-substituted aliphatic carboxylic acids | ETHYL CORPORATION (US) | 1994-01-11 | — | — | US | disclosed |
| US-5260482-A | Enantiomeric resolution | ETHYL CORPORATION (US) | 1993-11-09 | — | — | US | disclosed |
| US-5256816-A | Enantiomeric resolution | ETHYL CORPORATION (US) | 1993-10-26 | — | — | US | disclosed |
| US-5248813-A | Enantiomeric resolution | ETHYL CORPORATION (US) | 1993-09-28 | — | — | US | disclosed |
| US-4808620-A | ANTIINFLAMMATORY, ANALGESICS, ANTIPYRETIC, ANTIALLERGENS, ANTIARTHRITIC, ANTIRHEUMATIC AGENTS | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1989-02-28 | — | — | US | disclosed |
| EP-0254241-A1 | Pyrazolopyridine compounds, their preparation and use | Yoshitomi Pharmaceutical Industries, Ltd. (JP) | 1988-01-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076147-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | ADSL, SLC19A1, SLC25A21 | POLB 2457/4885GAA 394/4885NPSR1 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.